News & Views | Published:

BCAT1 defines gliomas by IDH status

Nature Medicine volume 19, pages 816817 (2013) | Download Citation

Metabolic alterations, such as those caused by mutations in the enzyme isocitrate dehydrogenase (IDH), define a clinically distinct subset of primary brain cancers. Expression of BCAT1 is now reported as a new metabolic change defining brain cancers without IDH mutations (pages 901–908).

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Trends Biochem. Sci. 35, 427–433 (2010).

  2. 2.

    et al. Nature 497, 633–637 (2013).

  3. 3.

    et al. Proc. Natl. Acad. Sci. USA 110, 8882–8887 (2013).

  4. 4.

    et al. Nat. Med. 19, 901–908 (2013).

  5. 5.

    , & Nutr. 135, 1557S–1564S (2005).

  6. 6.

    & Nutr. 136, 237S–242S (2006).

  7. 7.

    & Engl. J. Med. 359, 492–507 (2008).

  8. 8.

    et al. N. Engl. J. Med. 360, 765–773 (2009).

  9. 9.

    et al. Cancer Cell 17, 510–522 (2010).

  10. 10.

    et al. Science 321, 1807–1812 (2008).

  11. 11.

    et al. Science 340, 626–630 (2013).

  12. 12.

    & Genes Dev. 27, 836–852 (2013).

Download references

Author information

Affiliations

  1. Jared R. Mayers and Matthew G. Vander Heiden are at the Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

    • Jared R Mayers
    •  & Matthew G Vander Heiden
  2. Matthew G. Vander Heiden is also at the Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

    • Matthew G Vander Heiden

Authors

  1. Search for Jared R Mayers in:

  2. Search for Matthew G Vander Heiden in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Matthew G Vander Heiden.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm.3263

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing